<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AOpioid</id>
	<title>Definition:Opioid - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AOpioid"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Opioid&amp;action=history"/>
	<updated>2026-06-15T22:07:44Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Opioid&amp;diff=9516&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Opioid&amp;diff=9516&amp;oldid=prev"/>
		<updated>2026-03-11T05:29:44Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;💊 &amp;#039;&amp;#039;&amp;#039;Opioid&amp;#039;&amp;#039;&amp;#039;, in the context of the insurance industry, refers to a class of drugs — including prescription painkillers like oxycodone and fentanyl as well as illicit substances like heroin — whose widespread misuse has generated massive [[Definition:Insurance claim | claims]] exposure across multiple lines of coverage, most notably [[Definition:General liability insurance | general liability]], [[Definition:Product liability insurance | product liability]], [[Definition:Workers&amp;#039; compensation insurance | workers&amp;#039; compensation]], [[Definition:Health insurance | health]], and [[Definition:Life insurance | life insurance]]. The opioid epidemic has driven some of the largest [[Definition:Mass tort | mass tort]] litigations in American history, with pharmaceutical manufacturers, distributors, and retail pharmacies facing billions of dollars in settlements and verdicts. For insurers, opioid-related risk has reshaped [[Definition:Underwriting | underwriting]] practices, [[Definition:Loss reserving | reserving]] assumptions, and portfolio strategies across both personal and commercial lines.&lt;br /&gt;
&lt;br /&gt;
📉 The impact radiates through the industry in distinct ways depending on the line of business. [[Definition:Workers&amp;#039; compensation insurance | Workers&amp;#039; compensation]] carriers have seen inflated claim costs as injured workers prescribed opioids develop dependency, prolonging disability durations and increasing medical expenses. [[Definition:Health insurance | Health insurers]] face elevated treatment costs for addiction recovery, overdose emergency care, and medication-assisted treatment programs, prompting many to implement stricter [[Definition:Utilization review | utilization review]] and [[Definition:Formulary | formulary]] controls. On the [[Definition:Liability insurance | liability]] side, insurers that wrote [[Definition:Product liability insurance | product liability]] or [[Definition:General liability insurance | general liability]] policies for pharmaceutical companies and distributors have confronted coverage disputes centering on whether opioid-related harm constitutes a covered [[Definition:Occurrence | occurrence]] or falls under [[Definition:Pollution exclusion | absolute pollution]] or [[Definition:Expected or intended injury exclusion | expected-injury]] exclusions. These disputes have produced a complex and still-evolving body of [[Definition:Insurance coverage litigation | coverage litigation]].&lt;br /&gt;
&lt;br /&gt;
⚠️ Beyond direct claims costs, the opioid crisis has prompted regulatory and legislative action that reshapes the insurance landscape. Several states have imposed assessments on insurers to fund addiction treatment infrastructure, and underwriters now scrutinize pharmaceutical and healthcare accounts far more carefully for opioid-adjacent exposure. [[Definition:Actuarial science | Actuaries]] have had to adjust [[Definition:Mortality table | mortality assumptions]] in life insurance pricing, as opioid-related deaths have contributed to declining life expectancy in certain demographics. The crisis also illustrates a broader lesson about latent [[Definition:Casualty insurance | casualty]] exposure: like [[Definition:Asbestos | asbestos]] before it, opioid liability demonstrates how societal harm can metastasize into systemic insurance losses that take decades to fully quantify and resolve.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Mass tort]]&lt;br /&gt;
* [[Definition:Product liability insurance]]&lt;br /&gt;
* [[Definition:Workers&amp;#039; compensation insurance]]&lt;br /&gt;
* [[Definition:Loss reserving]]&lt;br /&gt;
* [[Definition:Social inflation]]&lt;br /&gt;
* [[Definition:Latent liability]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>